Updated from 3:16 p.m. EDT
Buoyed by the idea that swine flu fears could at least temporarily boost sales at some firms, health care stocks were largely in the green Monday.
GlaxoSmithKline (GSK), which makes antiviral drug Relenza, was among the day's early winners. The company, which issued a press release Monday that said it had sent Mexican officials 100,000 packs of Relenza and 170,000 additional doses of its seasonal flu vaccine, is "urgently assessing" ways to increase production of Relenza. Shares of the company rose 7.6% to $31.56. Novavax (NVAX), which owns technology for creating vaccines, rose 79.6% to $2.55.
Pfizer (PFE) shares rose 2.4% to $13.49 a day before the company's quarterly earnings report. Analysts expect the Lipitor maker, which is buying Wyeth (WYE), to report earnings of 49 cents on $11.08 billion in revenue, according to Thomson One.Bristol-Myers Squibb (BMY), which also reports earnings Tuesday, rose 2.2% to $20.54. Analysts polled by Thomson One expect the firm to earn 47 cents per share on $5.13 billion in revenue. Elsewhere: Eli Lilly (LLY) shares rose 0.4% to $33.13. Johnson & Johnson (JNJ) fell 0.1% to $50.86. Merck (MRK) was essentially flat at $23.44. Novo Nordisk (NVO) fell 2.6% to $47.49. The company reports earnings Thursday. Abbott Labs (ABT) rose 0.2% to $43.16.
Schering-Plough (SGP) rose 0.1% to $22.19.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV